Stock PPBT PURPLE BIOTECH LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Purple Biotech Ltd. TEL AVIV STOCK EXCHANGE

Equities

PPBT

IL0007650166

Biotechnology & Medical Research

Business Summary

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Managers

Managers TitleAgeSince
Gil Efron CEO
 Chief Executive Officer 57 11/18/11
Lior Fhima DFI
 Director of Finance/CFO - 02/22/02
Ido Morpurgo COO
 Chief Operating Officer 51 01/20/01
Hadas Reuveni CTO
 Chief Tech/Sci/R&D Officer 56 01/17/01
Bertrand C. Liang CTO
 Chief Tech/Sci/R&D Officer 61 09/20/09
Isaac Israel BRD
 Director/Board Member 44 01/12/01
Simcha Rock BRD
 Director/Board Member 73 11/13/11
Yisrael Gewirtz AUD
 Comptroller/Controller/Auditor 47 01/16/01
William Berlin PRN
 Corporate Officer/Principal - -
Michael Schickler LAW
 General Counsel 55 01/20/01

Members of the board

Members of the board TitleAgeSince
Eric Rowinsky CHM
 Chairman 67 02/19/02
Yael Margolin BRD
 Director/Board Member 70 20/12
Simcha Rock BRD
 Director/Board Member 73 11/13/11
Ido Agmon BRD
 Director/Board Member 46 27/16/27
Robert Gagnon BRD
 Director/Board Member 49 03/21/03
Suzana Nahum Zilberberg BRD
 Director/Board Member 53 19/21/19
Isaac Israel BRD
 Director/Board Member 44 01/12/01
Ori Hershkovitz BRD
 Director/Board Member 49 29/21/29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 259,905,127 258,842,627 ( 99.59 %) 0 99.59 %

Shareholders

NameEquities%Valuation
Jason Carrick
4.056 %
10,520,000 4.056 % 706 418 ₪
KSM Mutual Funds Ltd.
0.1415 %
367,133 0.1415 % 24 653 ₪
Migdal Mutual Funds Ltd.
0.0875 %
226,876 0.0875 % 15 235 ₪
NameEquities%Valuation
Armistice Capital LLC
9.635 %
2,499,384 9.635 % 2 M ₪
Armistice Capital LLC
7.256 %
1,882,173 7.256 % 1 M ₪
6 Dimensions Capital
0.7484 %
194,139 0.7484 % 130 073 ₪
Kingswood Wealth Advisors LLC
0.7174 %
186,100 0.7174 % 124 687 ₪
Morgan Stanley Capital Services LLC
0.3335 %
86,513 0.3335 % 57 964 ₪
Venture Visionary Partners LLC
0.0600 %
15,553 0.0600 % 10 421 ₪
Wealth Advisors of Iowa LLC
0.0550 %
14,270 0.0550 % 9 561 ₪
XTX Topco Ltd.
0.0523 %
13,561 0.0523 % 9 086 ₪
Geode Capital Management LLC
0.0488 %
12,666 0.0488 % 8 486 ₪
Citadel Securities GP LLC
0.0454 %
11,777 0.0454 % 7 891 ₪

Company contact information

Purple Biotech Ltd.

Science Park 4 Oppenheimer Street

7670104, Rehovot

+972 3 933 3121

http://ww.purple-biotech.com
address Purple Biotech Ltd.(PPBT)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.65% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+6.75% 101B
ARGENX SE Stock argenx SE
+6.52% 23.07B
BIONTECH SE Stock BioNTech SE
-12.60% 22.23B
GENMAB A/S Stock Genmab A/S
-5.43% 18.05B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.18B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.17% 16.94B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.12% 14.07B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.47% 12.35B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. PPBT Stock
  4. PPBT Stock
  5. Company Purple Biotech Ltd.